Meeting Treatment Goals in Patients on Extramural Dialysis in Health Social Security in Mexico.

Introduction: For the majority of renal replacement therapy history, the main treatment option for patients with end-stage renal disease (ESRD) in Mexico has been peritoneal dialysis. However, the use of hemodialysis is overwhelmingly increasing, driving public health care institutions to subrogate this service. Even when the actual hiring model for subrogation is accurate, there is a lack of quality control points in the hemodialysis prescription, poor adherence to clinical practice guidelines, and a few or no record of outcomes in hemodialysis patients of these subrogated services.

[Modification of health-related quality of life in kidney transplant recipients].

Introduction: The assessment of health-related quality of life is essential to renal replacement therapies. We conducted a study to evaluate the change in quality of life at 6 and 12 months after renal transplantation and compared with healthy population and general population.

Methods: A prospective study in 278 renal transplant recipients using the SF-36 survey at 0, 6 and 12 months after transplantation.

Nanoparticles vs cancer: a multifuncional tool.

Nanotechnology is revolutionizing the development of different branches of science. The investigation of nanomaterials in the battle against cancer is not an exception. The main goal of this contribution is to bring an overview about the types of organic and inorganic nanomaterials that are under investigation for its applications in different aspects of cancer therapy: detection, diagnosis, contrast agents, controlled drug delivery, and hyperthermia.

Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.

Background: Transfusion-transmitted viral infection (TTI) is a major problem in patients receiving blood products. Monitoring high-risk patients is essential for assessing the epidemiology of blood-borne infections.

Study Design And Methods: A 1-year, cross-sectional seroprevalence study in patients with a history of multiple transfusions was conducted.